Population pharmacokinetic model for regorafenib: A meta-analysis.

Joachim Grevel,I. Sturm,John Lettieri,Jean Smeets

Population pharmacokinetic model for regorafenib: A meta-analysis.

2015

Joachim Grevel
I. Sturm
John Lettieri
Jean Smeets

e13580 Background: The multikinase inhibitor regorafenib (REG) has shown clinical efficacy in metastatic colorectal cancer and advanced gastrointestinal stromal tumors. REG is primarily metabolized...

Keywords:

Regorafenib
Meta-analysis
Physical therapy
Oncology
Population
Medicine
Internal medicine
Pharmacokinetics
Pathology
Colorectal cancer
clinical efficacy
Stromal cell
multikinase inhibitor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations